참고문헌
- Barbagallo SG, Barbagallo M, Giordano M, Meli M, Panzarasa R. Alpha-Glycerophosphocholine in the mental recovery of cerebral ischemic attacks. An Italian multicenter clinical trial. Ann NY Acad Sci. 1994. 717: 253-269. https://doi.org/10.1111/j.1749-6632.1994.tb12095.x
- Cummings JL, Benson F. Subcortical dementia: Review of an emerging concept. Arch Neurol. 1984. 41: 874-879. https://doi.org/10.1001/archneur.1984.04050190080019
- Doggrell SA, Evans S. Treatment of dementia with neurotransmission modulation. Expert Opin Investig Drugs. 2003. 12: 1633-1654. https://doi.org/10.1517/13543784.12.10.1633
- Fossati T, Colombo M, Castiglioni C, Abbiati G. Determination of plasma choline by high-performance liquid chromatography with a postcolumn enzyme reactor and electrochemical detection. J Chromatogr B Biomed Appl. 1994. 656: 59-64. https://doi.org/10.1016/0378-4347(94)00070-0
-
Gatti G, Barzaghi N, Acuto G, Fossati T, Perucca E, Abbiatti G. A comparative study of free plasma choline levels following intramuscular administration of L-
${\alpha}$ -glycerylphosphorylcholine and citicoline in normal volunteers. Int J Clin Pharmacol Ther. 1992. 30: 331-335. - Grossman H, Bergmann C, Parker S. Dementia: A brief review. Mt Sinai J Med. 2006. 73: 985-992.
- Kidd PM. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Altern Med Rev. 2008. 13: 85-115.
- Majahabulin S. Enzymatic synthesis of sugar fatty acid esters in organic solvent and in supercritical carbon dioxide and their antimicrobial activity. J Supercrit Fluids. 2008. 45: 338-345. https://doi.org/10.1016/j.supflu.2008.01.002
- Moreno DJ. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clin. Ther. 2003. 25: 178-193. https://doi.org/10.1016/S0149-2918(03)90023-3
- Parnetti L, Mignini F, Tomassoni D, Traini E, Amenta F. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation. J Neurol Sci. 2007. 257: 264-269. https://doi.org/10.1016/j.jns.2007.01.043
- Park SY, Choi SU, Lee KH, Yang JB, Cho, SW, Ro JE, Kim HG, Khadka P, Lee JH, Cho CW. Discriminative measurement and pharmacokinetic evaluation of choline alphoscerate against endogenous choline in human. Bull Korean Chem Soc. 2015. 36: 2089-2094. https://doi.org/10.1002/bkcs.10409
- Sheard NF, Tayek JA, Bistrian BR, Blackburn GL, Zeisel SH. Plasma choline concentration in humans fed parenterally. Am J Clin Nutr. 1986. 43: 219-224. https://doi.org/10.1093/ajcn/43.2.219
- Sheard NF, Zeisel SH. An in vitro study of choline uptake by intestine from neonatal and adult rats. Pediatr Res. 1986. 20: 768-72. https://doi.org/10.1203/00006450-198608000-00014
- Trainia E, Bramantib V, Amenta F. Choline alphoscerate (alphaglyceryl-phosphoryl-choline) an old choline-containing phospholipid with a still interesting profile as cognition enhancing agent. Curr Alzheimer Res. 2013. 10: 1070-1079. https://doi.org/10.2174/15672050113106660173